Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Trisalus Life Sciences Inc (TLSI)

Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Trisalus Life Sciences Inc 6272 W 91st Ave Westminster CO 80031 USA

www.trisaluslifesci.com Employees: 110 P: 888-321-5212

Sector:

Medical

Description:

TriSalus Life Sciences Inc. is an oncology company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors. TriSalus Life Sciences Inc., formerly known as MedTech Acquisition Corporation, is based in CHICAGO.

Key Statistics

Overview:

Market Capitalization, $K 370,733
Enterprise Value, $K 384,283
Shares Outstanding, K 49,964
Annual Sales, $ 29,430 K
Annual Net Income, $ -30,050 K
Last Quarter Sales, $ 11,570 K
Last Quarter Net Income, $ -10,810 K
EBIT, $ -31,240 K
EBITDA, $ -29,880 K
60-Month Beta 0.43
% of Insider Shareholders 27.50%
% of Institutional Shareholders 2.58%
Float, K 36,224
% Float 72.50%
Short Interest 755
Short Float 1.51%
Short Volume Ratio 0.55

Growth:

1-Year Return 84.20%
3-Year Return -26.02%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.96 on 11/13/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -1.91
EPS Growth vs. Prev Qtr -255.56%
EPS Growth vs. Prev Year -140.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TLSI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -111.88%
Profit Margin % -102.11%
Debt/Equity -1.23
Price/Sales 12.60
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.54
Interest Coverage -8.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar